AN OPEN-LABEL INVESTIGATOR SPONSORED TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY AND DEVELOPMENT OF SUBFOVEAL FIBROSIS BY INTRAVITREAL ADMINISTRATION OF ALTERING REGIMENS OF FOVISTA AND ANTI-VEGF THERAPY IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: